SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-159568
Filing Date
2009-07-30
Accepted
2009-07-30 16:16:37
Documents
8
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 445536
2 AMENDMENT NO. 1 TO THE SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 17837
3 FORM OF AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT dex102.htm EX-10.2 80214
4 FOURTH AMENDMENT dex103.htm EX-10.3 23488
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6255
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6235
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3493
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3464
  Complete submission text file 0001193125-09-159568.txt   588006
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
MDRNA, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 09973958
SIC: 2834 Pharmaceutical Preparations